Literature DB >> 14717477

Noncompliance leading to drug accumulation resulting in phenytoin toxicity.

Ravi Akula1, Syed Hasan, Rao Pipalla, Clifford Ferguson.   

Abstract

Phenytoin is effective in suppressing tonic-clonic and partial seizures, and is widely used for initial therapy, particularly in adults. Ninety percent of phenytoin is protein bound and entirely eliminated by hepatic metabolism. The major metabolite of phenytoin, 5-(p-hydroxyphenyl)-5phenylhy-dantoin (5HPPH) is excreted in the urine. Higher phenytoin levels for a given dose of phenytoin can be seen in alcohol intoxication, hepatic and renal failures, hypoalbuminemia, nephrotic syndrome, trauma, and AIDS. Noncompliance can lead to accumulation of the drug-causing toxicity. We present a patient with acute alcohol intoxication who developed phenytoin toxicity due to noncompliance with the drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14717477      PMCID: PMC2594850     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  8 in total

1.  INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY.

Authors:  H KUTT; M WOLK; R SCHERMAN; F MCDOWELL
Journal:  Neurology       Date:  1964-06       Impact factor: 9.910

2.  Phenytoin toxicity in an older patient with slow metabolism and atypical presentation.

Authors:  J K Pitner; L D Long; R P Meyer; L C Pennypacker
Journal:  Pharmacotherapy       Date:  1998 Jan-Feb       Impact factor: 4.705

3.  Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin.

Authors:  R S Kidd; T B Curry; S Gallagher; T Edeki; J Blaisdell; J A Goldstein
Journal:  Pharmacogenetics       Date:  2001-12

4.  Inheritance of phenytoin hypometabolism: a kinetic study of one family.

Authors:  M R Vasko; R D Bell; D D Daly; C E Pippenger
Journal:  Clin Pharmacol Ther       Date:  1980-01       Impact factor: 6.875

5.  Some causes of ineffectiveness of diphenylhydantoin.

Authors:  H Kutt; J Haynes; F McDowell
Journal:  Arch Neurol       Date:  1966-05

6.  Severe phenytoin intoxication in a subject homozygous for CYP2C9*3.

Authors:  R Brandolese; M G Scordo; E Spina; M Gusella; R Padrini
Journal:  Clin Pharmacol Ther       Date:  2001-10       Impact factor: 6.875

7.  Phenytoin kinetics in Japanese adult epileptics: phenotype of phenytoin slow metabolizers.

Authors:  M Watanabe; K Iwahashi; T Kugoh; H Suwaki
Journal:  Clin Neuropharmacol       Date:  1997-08       Impact factor: 1.592

8.  The rate of decline of diphenylhydantoin in human plasma.

Authors:  K Arnold; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.903

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.